Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;58(6):2770-2779.
doi: 10.1007/s12035-021-02303-2. Epub 2021 Jan 26.

Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies

Anderson Velasque Catarina  1 , Gisele Branchini  2 , Lais Bettoni  2 , Jarbas Rodrigues De Oliveira  3 , Fernanda Bordignon Nunes  2   3
Affiliations
Review

Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies

Anderson Velasque Catarina et al. Mol Neurobiol. 2021 Jun.

Abstract

Sepsis is an organ dysfunction caused by an uncontrolled inflammatory response from the host to an infection. Sepsis is the main cause of morbidity and mortality in intensive care units (ICU) worldwide. One of the first organs to suffer from injuries resulting from sepsis is the brain. The central nervous system (CNS) is particularly vulnerable to damage, mediated by inflammatory and oxidative processes, which can cause the sepsis-associated encephalopathy (SAE), being reported in up to 70% of septic patients. This review aims to bring a summary of the main pathophysiological changes and dysfunctions in SAE, and the main focuses of current experimental studies for new treatments and therapies. The pathophysiology of SAE is complex and multifactorial, combining intertwined processes, and is promoted by countless alterations and dysfunctions resulting from sepsis, such as inflammation, neuroinflammation, oxidative stress, reduced brain metabolism, and injuries to the integrity of the blood-brain barrier (BBB). The treatment is limited once its cause is not completely understood. The patient's sedation is far to provide an adequate treatment to this complex condition. Studies and experimental advances are important for a better understanding of its pathophysiology and for the development of new treatments, medicines, and therapies for the treatment of SAE and to reduce its effects during and after sepsis.

Keywords: Brain; Encephalopathy; Experimental studies; Sepsis.

PubMed Disclaimer

References

    1. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS et al (2016) Developing a newdefinition and assessing newclinical criteria for Septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc 315(8):775–787
    1. Gotts JE, Matthay MA (2016) Sepsis: pathophysiology and clinical management. BMJ 353:1–20
    1. Delano MJ, Ward PA (2016) Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest 126(1):23–31 - PubMed - PMC
    1. Schulte W, Bernhagen J, Bucala R (2013) Cytokines in sepsis: potent immunoregulators and potential therapeutic targets - an updated view. Mediators Inflamm 2013.
    1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228 - PubMed - PMC

Grants and funding

LinkOut - more resources